In addition, high YTHDF2 transcription was associated with a higher survival rate and increased tumor-infiltrating lymphocytes in clear cell renal cell carcinoma and NSCLC patients, suggesting the antitumor function of YTHDF2 (Su et al., 2021; Tsuchiya et al., 2021). Here, YTHDF2 is linked to neoplasm.